Chemotherapy combined with endocrine neoadjuvant therapy for hormone receptor-positive local advanced breast cancer: a case report and literature review
ConclusionsA novel approach involving concurrent neoadjuvant therapy with CT and endocrine therapy may offer a potentially effective treatment avenue for some cases with HR+ LABC.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Endocrine Therapy | Endocrinology | Hormones | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study | Xeloda